Abcam Financial Statements From 2010 to 2026
| ABCZFDelisted Stock | USD 22.25 0.00 0.00% |
Check Abcam Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abcam Plc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Abcam financial statements analysis is a perfect complement when working with Abcam Plc Valuation or Volatility modules.
Abcam |
Abcam Plc Company Current Valuation Analysis
Abcam Plc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abcam Plc Current Valuation | 3.69 B |
Most of Abcam Plc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abcam Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Abcam Plc has a Current Valuation of 3.69 B. This is 74.32% lower than that of the Healthcare sector and 20.61% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 77.82% higher than that of the company.
Abcam Plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abcam Plc's current stock value. Our valuation model uses many indicators to compare Abcam Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcam Plc competition to find correlations between indicators driving Abcam Plc's intrinsic value. More Info.Abcam Plc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 4.72 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abcam Plc's earnings, one of the primary drivers of an investment's value.About Abcam Plc Financial Statements
Abcam Plc stakeholders use historical fundamental indicators, such as Abcam Plc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abcam Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abcam Plc's assets and liabilities are reflected in the revenues and expenses on Abcam Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abcam Plc. Please read more on our technical analysis and fundamental analysis pages.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. ABCAM PLC operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1682 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Abcam Pink Sheet
If you are still planning to invest in Abcam Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abcam Plc's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |